tiprankstipranks
Design Therapeutics reports Q2 EPS (21c), consensus (23c)
PremiumThe FlyDesign Therapeutics reports Q2 EPS (21c), consensus (23c)
6M ago
DSGN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DSGN Upcoming Earnings Report: What to Expect?
6M ago
Design Therapeutics reports Q1 EPS (20c), consensus (26c)
Premium
The Fly
Design Therapeutics reports Q1 EPS (20c), consensus (26c)
9M ago
Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
PremiumCompany AnnouncementsDesign Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
10M ago
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
Premium
The Fly
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
11M ago
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
11M ago
Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
PremiumMarket NewsMultiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
1y ago
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
Premium
The Fly
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
1y ago
Design Therapeutics downgraded to Market Perform at SVB Securities
Premium
The Fly
Design Therapeutics downgraded to Market Perform at SVB Securities
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100